Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Arrivo BioVentures

Arrivo BioVentures

Working in partnership with investors, innovators, and pharmaceutical companies, Arrivo is always seeking solutions for unmet medical needs. Arrivo strives to set a new standard that starts with the selection of drug candidates through clinical development. Arrivo has built a portfolio of diverse drug candidates with the potential to be first-in-class or best-in-class. It is not just the products that are novel. Arrivo's entire approach is novel. The company's unique form of drug development has resulted in a history of product successes and excellent returns. The company stands on a solid foundation as the team has an average of more than 25 years of experience in drug development. Arrivo is founded and led by a team that has built and sold four companies in the last 15 years. Two products are currently commercially available and helping patients. Arrivo is propelled forward by its insatiable curiosity and drive to solve complex problems and help millions of patients globally. Arrivo is based in Morrisville, N.C., on the edge of Research Triangle Park.

Last updated on

About Arrivo BioVentures

Founded

2015

Estimated Revenue

$1M-$10M

Employees

1-10

Funding / Mkt. Cap

$94M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

SIC Code

28

NAICs Code

3254

Location

City

Morrisville

State

North Carolina

Country

United States
Arrivo BioVentures

Arrivo BioVentures

Find your buyer within Arrivo BioVentures

Tech Stack (27)

search